ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · IEX Real-Time Price · USD

1.985

+0.065 (3.39%)

At close: May 2, 2024, 4:00 PM

2.020

+0.035 (1.76%)

After-hours: May 2, 2024, 4:23 PM EDT

ProMIS Neurosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	12.6	5.88	16.94	0.81
Short-Term Investments	0.03	0.03	0.03	0.03
Cash & Cash Equivalents	12.63	5.91	16.98	0.84
Cash Growth	113.83%	-65.21%	1921.45%	-
Other Current Assets	0.99	1	0.74	0.13
Total Current Assets	13.62	6.9	17.71	0.97
Property, Plant & Equipment	0	0	0	0.08
Goodwill and Intangibles	0	0.02	0.03	0.03
Other Long-Term Assets	0	0	0	0
Total Long-Term Assets	0	0.02	0.03	0.11
Total Assets	13.62	6.92	17.75	1.09
Accounts Payable	7.84	2.98	0.41	0.44
Other Current Liabilities	1.51	3.44	0.52	1.45
Total Current Liabilities	9.35	6.41	0.93	1.88
Long-Term Debt	0	0	3.91	0
Other Long-Term Liabilities	0.52	1.86	7.25	0
Total Long-Term Liabilities	0.52	1.86	11.16	0
Total Liabilities	9.87	8.27	12.09	1.88
Total Debt	0	0	3.91	0
Retained Earnings	-93.47	-80.25	-62.19	-52.4
Comprehensive Income	-0.37	-0.2	-0.19	-0.05
Shareholders' Equity	3.75	-1.35	5.66	-0.8
Net Cash / Debt	12.63	5.91	13.07	0.84
Net Cash / Debt Growth	113.83%	-54.81%	1456.36%	-
Net Cash Per Share	1.03	0.79	2.26	0.18
Working Capital	4.27	0.49	16.79	-0.91
Book Value Per Share	0.30	-0.18	0.98	-0.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).